SU5204

CAS No. 186611-11-0

SU5204( 3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one )

Catalog No. M22955 CAS No. 186611-11-0

SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 30 In Stock
5MG 28 In Stock
10MG 42 In Stock
25MG 75 In Stock
50MG 110 In Stock
100MG 177 In Stock
200MG 259 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU5204
  • Note
    Research use only, not for human use.
  • Brief Description
    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
  • Description
    SU5204, an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR2|HER2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    186611-11-0
  • Formula Weight
    265.31
  • Molecular Formula
    C17H15NO2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (376.92 mM)
  • SMILES
    O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Peng Cho Tang, et al. 3-heteroaryl-2-indolinone compounds for the treatment of disease. US5792783A.
molnova catalog
related products
  • Lariciresinol

    Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

  • GSK269962A

    GSK269962 is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.

  • 8-O-Acetylshanzhisid...

    8-O-Acetylshanzhiside methylester has potential against cerebral ischemic injury, and its protective effect on oxygen-glucose deprivation-induced injury might be due to the suppression of intracellular Ca2+ elevation and caspase-3 activity.